SAFETY AND EFFICACY OF COMBINATION OF BRENTUXIMAB VEDOTIN AND NIVOLUMAB IN RELAPSED / REFRACTORY HODGKIN LYMPHOMA: a TRIAL OF THE ECOGâACRIN CANCER RESEARCH GROUP (E4412)
Hematological Oncology | June 7, 2017 | Volume: 35 | Issue: S2 | Pages: 84-85
10.1002/hon.2437_72